Regression of pigmented lesions in a patient with metastatic melanoma treated with immunotherapy

Zachary Schwager; Mary E Laird; Jo-Ann Latkowski

doi:10.1016/j.jdcr.2017.10.019

Regression of pigmented lesions in a patient with metastatic melanoma treated with immunotherapy

JAAD Case Rep. 2018 Apr 30;4(5):421-423. doi: 10.1016/j.jdcr.2017.10.019. eCollection 2018 Jun.

Authors

Zachary Schwager^{1

2}, Mary E Laird^{1

2}, Jo-Ann Latkowski^{1

2}

Affiliations

¹ New York Harbor Veterans Affairs Medical Center, New York, New York.
² The Ronald O. Perelman Department of Dermatology, New York University, New York, New York.

No abstract available

Keywords: CTLA-4, cytotoxic T-lymphocyte–associated protein 4; PD-1, Programmed cell death protein 1; immunotherapy; melanoma; nevi; programmed cell death protein 1 inhibitors.

Publication types

Case Reports